Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Hoffmann-La Roche
Condition: Prostate Cancer
NCT02480010
A Study of Pertuzumab in Participants With Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
The study was terminated at the time of interim analysis since none of the participants showed a PSA response.